These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 12875710

  • 1. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
    Wang Z, Liao Y, Dong J, Li S, Wang J, Fu ML.
    Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S.
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [Abstract] [Full Text] [Related]

  • 3. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B, Padberg K, Schultheiss HP, Strauer BE.
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [Abstract] [Full Text] [Related]

  • 4. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody.
    Yuan HT, Liao YH, Wang Z, Dong JH, Cao LS, Wang ZH, Wang JP, Fu ML.
    Can J Physiol Pharmacol; 2003 Feb; 81(2):84-8. PubMed ID: 12710519
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis.
    O'Donoghue HL, Lawson CM, Reed WD.
    Immunology; 1990 Sep; 71(1):20-8. PubMed ID: 2170269
    [Abstract] [Full Text] [Related]

  • 6. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Lüscher TF, Eriksson U.
    Circ Res; 2009 Oct 23; 105(9):912-20. PubMed ID: 19762681
    [Abstract] [Full Text] [Related]

  • 7. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL, Vinci A, Iliceto S.
    Autoimmunity; 2008 Sep 23; 41(6):462-9. PubMed ID: 18781472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Dalla Volta S.
    G Ital Cardiol; 1997 Feb 23; 27(2):106-12. PubMed ID: 9199945
    [Abstract] [Full Text] [Related]

  • 11. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
    Morgun A, Shulzhenko N, Unterkircher CS, Diniz RV, Pereira AB, Silva MS, Nishida SK, Almeida DR, Carvalho AC, Franco M, Souza MM, Gerbase-DeLima M.
    J Heart Lung Transplant; 2004 Feb 23; 23(2):204-9. PubMed ID: 14761768
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
    Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D.
    Circ Res; 2010 May 28; 106(10):1646-55. PubMed ID: 20378858
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B, Richter A, Sandmöller A, Portig I, Pankuweit S, BMBF-Heart Failure Network.
    Herz; 2005 Sep 28; 30(6):535-44. PubMed ID: 16170686
    [Abstract] [Full Text] [Related]

  • 15. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
    Lawson CM, O'Donoghue HL, Reed WD.
    Immunology; 1992 Mar 28; 75(3):513-9. PubMed ID: 1315309
    [Abstract] [Full Text] [Related]

  • 16. [Effects of immunotherapy with anti-L3T4 monoclonal antibody on autoimmune cardiomyopathy: experiment with mice].
    Yuan J, Liao YH, Wang ZH, Cheng X, Zhang JH, Dong JH, Wang M.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3346-9. PubMed ID: 16409842
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D, Rose NR.
    Adv Immunol; 2008 Dec 14; 99():95-114. PubMed ID: 19117533
    [Abstract] [Full Text] [Related]

  • 18. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
    Horwitz MS, Ilic A, Fine C, Sarvetnick N.
    J Autoimmun; 2005 Sep 14; 25(2):102-11. PubMed ID: 16011890
    [Abstract] [Full Text] [Related]

  • 19. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
    Caforio AL, Mahon NJ, Mckenna WJ.
    Autoimmunity; 2001 Sep 14; 34(3):199-204. PubMed ID: 11908778
    [Abstract] [Full Text] [Related]

  • 20. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
    Neumann DA, Rose NR, Ansari AA, Herskowitz A.
    J Immunol; 1994 Jan 01; 152(1):343-50. PubMed ID: 8254202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.